EV/EBITDA
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary:
Nymox Pharmaceutical EV/EBITDA is not available.NYMX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| 6 m6 months | - |
| 1 y1 year | - |
| 5 y5 years | - |
NYMX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | ||||
| 3 y | 3 years | -1.28 | -49.26 | ||
| 5 y | 5 years | -1.28 | -49.26 | ||
| alltime | all time | -1.28 | -167.85 |
Nymox Pharmaceutical EV/EBITDA History
| Date | Value |
|---|---|
| 2022 | -4.41(-51.3%) |
| 2021 | -9.05(-45.8%) |
| 2020 | -16.70(+38.6%) |
| 2019 | -12.05(+66.0%) |
| 2018 | -7.26(-48.1%) |
| 2017 | -14.00(+38.6%) |
| 2016 | -10.10(+26.4%) |
| 2015 | -7.99(+154.5%) |
| 2014 | -3.14(-92.7%) |
| 2013 | -42.97(+42.5%) |
| 2012 | -30.16(+9.1%) |
| 2011 | -27.65(-16.6%) |
| 2010 | -33.16(+14.3%) |
| Date | Value |
|---|---|
| 2009 | -29.00(+24.7%) |
| 2008 | -23.26(-34.5%) |
| 2007 | -35.52(+60.7%) |
| 2006 | -22.11(+21.5%) |
| 2005 | -18.20(-19.2%) |
| 2004 | -22.53(+7.1%) |
| 2003 | -21.04(-20.1%) |
| 2002 | -26.32(-15.1%) |
| 2001 | -31.00(+180.5%) |
| 2000 | -11.05(-33.7%) |
| 1999 | -16.66(-22.4%) |
| 1998 | -21.46(-60.6%) |
| 1997 | -54.43 |
FAQ
- What is the all time high EV/EBITDA for Nymox Pharmaceutical?
What is the all time high EV/EBITDA for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high EV/EBITDA is -1.28